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Abstract. The receptor-like protein tyrosine phospha- 
tase, PTP/x, displays tructural similarity to cell-cell 
adhesion molecules of the immunoglobulin superfam- 
ily. We have investigated the ability of human PTP# to 
function in such a capacity. Expression of PTP#, with 
or without he PTPase domains, by recombinant 
baculovirus infection of Sf9 cells induced their aggre- 
gation. However, neither a chimeric form of PTP#, 
containing the extracellular and transmembrane s g- 
ments of the EGF receptor and the intracellular seg- 
ment of PTP/z, nor the intracellular segment of PTP/~ 
expressed as a soluble protein induced aggregation. 
PTP# mediates aggregation via a homophilic mecha- 
nism, as judged by lack of incorporation of uninfected 
St9 cells into aggregates of PTP#-expressing cells. 
Homophilic binding has been demonstrated between 
PTP#-coated fluorescent beads (Covaspheres) and en- 
dogenously expressed PTP# on MvLu cells. Addition- 
ally the PTP/~-coated beads specifically bound to a 
bacterially expressed glutathione-S-transferase fu ion 
protein containing the extracellular segment of PTP# 
(GST/PTP/~) adsorbed to petri dishes. Covaspheres 
coated with the GST/PTP/~ fusion protein aggregated 
in vitro and also bound to PTP# expressed en- 
dogenously on MvLu cells. These results suggest that 
the ligand for this transmembrane PTPase is another 
PTP# molecule on an adjacent cell. Thus homophilic 
binding interactions may be an important component 
of the function of PTP/~ in vivo. 
T 
hE reversible phosphorylation f tyrosyl residues in 
proteins is an essential component of the modulation 
of signal transduction processes involved in cell 
growth and differentiation. The dynamic balance of cellular 
phosphotyrosine levels is achieved by the opposing actions 
of the protein tyrosine kinases (PTKs) 1 and protein tyrosine 
phosphatases (PTPases). The P'rKs are a structurally di- 
verse group that includes growth factor eceptors and a sub- 
stantial number of oncogene products, including members of 
the src family. It is now apparent that PTPases rival the PTKs 
in structural diversity and complexity. PTPases have the 
potential to oppose the effects of kinases as illustrated by 
their ability to suppress the transforming potential of onco- 
genic PTKs (Brown-Shimer et al., 1992; Woodford-Thomas 
et al., 1992; Zander et al., 1993). However, the PTPases 
should not be viewed simply as PTK antagonists. Overex- 
pression of PTPot leads to dephosphorylation and activation 
ofc-src and induces cell transformation (Zheng et al., 1992). 
In addition, CD45 has been shown to play an essential role 
in signal transduction through the T cell receptor, also poten- 
tially exerting its effect hrough the dephosphorylation and 
activation of src-family PTKs such as lck and fyn (reviewed 
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in Trowbridge, 1991). Current evidence clearly indicates an 
essential role for the PTPases in cellular signaling. 
PTPases exist in both soluble and transmembrane, re- 
ceptor-like forms, (Charbonneau and Tonks, 1992). The 
structural features of some of the enzymes suggest arole for 
subeellular localization in the regulation of activity. In the 
case of the receptor PTPases, similar to the receptor PTKs, 
there is the potential for regulating activity by the binding of 
ligands to the extracellular segment of the protein. Several 
of the transmembrane PTPases are members of the immuno- 
globulin superfamily and display structural motifs in their 
extracellular segments that are suggestive of a role in 
cell-cell adhesion (Streuli et al., 1989; Fischer et al., 1991). 
Cell-cell adhesion molecules are grouped into two major 
families on the basis of homology and conditions for bind- 
ing: the immunoglobulin superfamily (generally calcium- 
independent) and the cadherin family (calcium-dependent). 
N-CAM is prototypical of the immunoglobulin superfamily 
of adhesion molecules. It contains five immunoglobulin do- 
mains and two fibronectin type-l]1 repeats in the extracellu- 
lar segment (reviewed by Edelman and Crossin, 1991). 
Cadherins are calcium-dependent cell-cell adhesion mole- 
cules that associate with the actin cytoskeleton by interac- 
tions of their cytoplasmic domains with proteins termed 
catenins (Ozawa et al., 1989). Both N-CAM and the cadhe- 
fins bind by a homophilic mechanism (Edelman et al., 1987; ~ 
Hall et al., 1990; Rao et al., 1992; Takeichi, 1991). 
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The receptor-type PTPase, PTP#, shows homology to 
N-CAM in that it bears an extracellular segment with an im- 
munoglobulin domain and four fibronectin type HI repeats 
(see Fig. 1) (Gebbink et al., 1991). This arrangement of mul- 
tiple Ig-domains and fibronectin type-Ill repeats was first ob- 
served in LAR (Streuli et al., 1988) and has also been seen 
in the extracellular segments ofseveral other transmembrane 
PTPases (reviewed in Charbonneau and Tonks, 1992). In 
this manuscript we investigate whether PTP# can participate 
in homophilic binding interactions. 
Introduction of potential adhesion molecules into non- 
adhesive Drosophila $2 insect cells has been used to demon- 
strate adhesive functions for fasciclin HI, connectin and Dtrk 
molecules directly (Snow et al., 1989; Nose et al., 1992; Pu- 
lido et al., 1992). In a similar approach, we demonstrate that 
the full-length form of PTPt~ induced aggregation, via a 
homophilic binding mechanism, when expressed in nonad- 
hesive St9 insect cells, which are derived from the Fall army- 
worm Spodopterafrugiperda. Cells expressing mutant forms 
of the enzyme lacking the natural extracellular segment did 
not aggregate. In this system, PTPase activity and the aggre- 
gation response are not mutually dependent. We have also 
reconstituted the binding reaction in vitro between baculo- 
virus-expressed PTP# linked to beads and surfaces coated 
with bacterially-expressed extracellular segment of PTP#. 
Finally we show that endogenously expressed PTP/z in lung 
calls binds homophilically to baculovirus-expressed PTP#. 
These data represent the first demonstration f homophilic 
binding and a potential adhesive function for a member of 
the PTPase family of enzymes. 
Materials and Methods 
Cell Culture and PTPase Activity 
SI9 cells derived from the ovary of the Fall armyworm Spodoptera 
frugiperda (American "Pype Culture Collection [ATCC] number CRL 1711) 
were maintained at27°C in Graces Insect Medium Supplemented (GIBCO- 
BRL, Gaithersburg, MD) containing 10% FBS and 10 t~g/ml gentamicin 
(GIBCO-BRL). MvLu and 3"1"3 cells (ATCC numbers CCL 64 and CCL 
92, respectively) were grown at 37°C, 5% CO2 in DME containing peni- 
cillin and streptomycin plus 10% FBS (GIBCO-BRL). 
PTPase assays were performed as described (Flint et al., 1993). Total 
cell iysates were prepared in detergent containing buffer (20 mM "Iris pH 
7.6, 5 mM EDTA, 1% Triton X-100, 5/~g/mi leupeptin, 5/~g/ml aprotinin, 
1 mM benzamidine, 1 mM PMSF, and 1 mM DTT). PTPase activity was 
measured in vitro by dephosphorylation of tyrosine-phosphorylated re- 
duced carboxamidomethylated an  maleylated (RCM) lysozyme. 1 U is 
defined as the amount of enzyme that catalyzes the release of I nmol phos- 
phate from the substrate per rain. 
Plasmid and Baculovirus Construction 
The soluble form (80 kD) and the full-length form (200 kD) of human PTP/~ 
were expressed in Sf9 cells infected with the Ac-pS and Ac-pFL 
baculoviruses, respectively. The soluble form (Ac-pS) contains the DNA se- 
quence coding for the intracellular domain of PTPp (amino acids 774- 
1452). pS was generated by digesting bluescript TR-PTP/~ (Gebbink et al., 
1991) with BamHI and XbaI and ligating the fragment into pVLI392 (In- 
vitrogen Corp., San Diego, CA). The fuU-length form of PTP/~ was cloned 
out of bhiescript containing the full-length eDNA of PTP/~ using the NotI 
and XbaI sites and ligated into pVLI392 (PTP/~ eDNA was provided by M. 
Gebbink and W. Moolenaar, Netherlands Cancer Institute). A chimeric 
form of PTPt~, pEGFR/PTPp (provided by R. Beijersbergen, Netherlands 
Cancer Institute) was generated that contained the extracellular nd trans- 
membrane domains of the EGF receptor (673 amino acids; base pair 170- 
2190) and the intracellular domain of Irl'P~ (678 amino acids; base pair 
2320-4865). These three viruses were generated by calcium phosphate 
mediated cotransfection ofSf9 cells with plasmid and viral DNA. Recom- 
binant viruses were isolated as described in Summers and Smith (1987). A 
mutant form of PTPt~ was generated that contained the extracellular do- 
main, the transmembrane domain and 54 amino acids of the intraceUular 
domain (Ac-PTP/~-extra). This mutant form lacks both pbosphatase do- 
mains and was called PTP/~-extra. This form was cloned into the pVL1393 
plasmid 0nvitrogen Corp.) using a Not I sile from the full length eDNA 
in bhiescript and the Bgl II site of the PTP~t intracellular domain. The 
recombinant virus was made using the BaculoGold Transfection System 0n- 
vitrogen Corp.). A 2.2-kb fragment encoding the 79 kD extracellular seg- 
ment of PTPt~ (amino acids 21-740) was generated using oligonucleotides 
and PCR and ligated into the pGEX-KG vector (provided by K. Guan and 
J. Dixon, University of Michigan, Ann Arbor, MI) to produce aGST fusion 
protein. This construct was designated GST/PTP#. The BIRK baculovirus 
has been described (Villalba et al., 1989). The tropomyosin baculovirus was 
provided by M. Pittenger and D. Helfman (Cold Spring Harbor Labo- 
ratory). 
Antibodies 
For isolation of the soluble (80 kD) form of PTP~, Sf9 cells were infected 
with Ac-pS recombinant baculovirus for 4 d. Soluble PTP/~ was purified 
from the cytoplasmic fraction of Sf9 cell lysates by sequential application 
to fast flow Q Sepbarose, Mono Q, and Mono S as described (Brady-Kalnay 
and Tonks, 1993). The purified protein was used to generate six mAbs. 
Each of the mAbs was characterized in terms of binding to PTP/~; none rec- 
ognized any proteins in extracts from uninfected Sf9 cells (manuscript in
preparation). All of the monoclonals recognized the fuU-length and soluble 
PTP# proteins from baculovirus-infected St9cells and COS cells tran- 
siently transfected with PTP~. One of the mAbs (SBK-15) was used for 
coupling PTP~ to Covaspheres and another antibody (SBK-10) was used in 
immunoblotting. A rabbit polyclonal antipeptide antibody to the amino ter- 
minus of PTP/~ (residues 42-57, provided by M. Gebbink) was used for 
detection of PTPt~ in irnmunoblots, coating of the MvLu cells and Fab' pro- 
duction. Fab' fragments ofthis antibody were generated according to Brack- 
enbury et al. (1977). Monoclonal anti-phospbotyrosine a tibody (4G10) 
was purchased from Upstate Biotechnology Inc. (catalog no. 05-321; Lake 
Placid, NY) and used at 1:1,000 dilution. 
Electrophoresis and Immunoblotting 
Sf9 cells were infected with Ac-pS, Ac-pFL, Ac-pEGFR/PTP#, or Ac- 
PTP/~-extra recombinant baculoviruses to express the various forms of 
PTP/~. For analysis of expression of the various proteins, cells were har- 
vested 42 h post-infection by centrifugation for 5 rain at 3,000 g, and lysed 
in 1 ml of buffer (20 mM Tris pH 7.6, 5 mM EDTA, 1% Triton X-100, 5 
t~g/ml leupeptin, 5/~g/ml aprotinin, 1mM benzamidine, 1 m.M PMSF, 200 
~,M phenyl arsine oxide, 1 mM vanadate and 0.1 mM molybdate). After in- 
cubation on ice for 30 min, the lysate was centrifuged at 10,000 g for 10 
rain and the supernatant was used for immunnblotting. The amount of pro- 
tein was determined bythe Bradford method using BSA as a standard (Brad- 
ford, 1976). 4x sample buffer was added to the lysates and they were sepa- 
rated by electrophoresis on 8% SDS polyacrylamide gels (Laemmli, 1970). 
Proteins were transferred tonitrocellulose (Towbin, 1979), blocked in 5% 
nonfat dry milk in TTBS, incubated with mAb (SBK-10) or polyclonal 
amino-terminal anti-peptide antibody against PTP#. A secondary antibody 
conjugated to HRP was added and the bound antibody was visualized 
by enhanced chemiluminescence (ECL, Amersham Corp., Arlington 
Heights, IL). 
Cell surface xpression ofthe various forms of PTP/z was verified by ex- 
amining their protease sensitivity on intact cells. St9 cells were removed 
from a T25 flask in 2 mls Grace's medium in the presence or absence of 
0.05 % trypsin (wt/vol) (Worthington Biochemical Corp., Freehold, NJ) and 
incubated for 15 min at room temperature. The cells were centrifuged, ex- 
tracted and immunoblotted as described above xcept hat lima bean trypsin 
inhibitor (Worthington Biochemical Corp., Freehold, N J) was added to the 
lysis buffer (60/~g/mi). 
Phosphotyrosine levels were compared by reactivity to an anti-phospho- 
tyrosine antibody on immunoblots. Co-infections were performed by simul- 
taneously adding both viruses to Sf9 cells and incubating for 42 h. The im- 
munnblots were performed as described above. 
Cell Aggregation Assays 
Sf9 adhesion assays were similar to those performed in Snow et al. (1989). 
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The quantitation of the extent of aggregation followed the procedure of 
Brackenbury et al. (1977). Sf9 cells were harvested 2 or 3 d post-infection. 
1 x 106 cells were added to 2 mls Grace's medium containing 150 t~g/ml 
DNase I in a glass scintillation vial (Fisher Scientific, Pittsburgh, PA) and 
incubated at 25 °C at 90-100 rpm in a gyratory shaker. Aliquots were diluted 
50-fold and the number of particles was determined using a Coulter 
Counter. The Coulter Counter settings were: lower threshold-5.0, upper 
threshold-99.9, current-500 mA, full scale-l, polarity-auto, attenua- 
tion-16, and preset gain-1. The percent aggregation was calculated by sub- 
tracting the particle number after the 30 rain or 1 h time point (N0 from 
the initial particle number (No) and dividing by the initial number {[(No - 
N0/No] X 100}. Aggregates were visualized with a phase contrast micro- 
scope using the 10x objective. 
Fluorescent labeling of cells using Di I was performed according to the 
protocol supplied by Molecular Probes Inc. (Eugene, Oregon). Sf9 cells 
were incubated with 20/tM Di I for 15 rain at room temperature, then 
washed two times in Graces medium. Di I labeled, uninfected Sf9 cells 
were mixed with an equal number of cells expressing full-length PTP# and 
aggregation assays were performed as described above. Aliquots were 
spotted onto microscope slides and Di I labeled cells were observed with 
a Zeiss Axiophot microscope quipped for epifluorescence using a 20x 
lens. 
In a subset of assays, a chelating resin, iminodiacetic acid cross-linked 
to polystryrene (Sigma Chemical Co., St. Louis, MO), was used to remove 
divalent cations from the insect cell medium. One ml swollen resin was used 
to deplete 3 ntis media by mixing for 1 h at room temperature. The effect 
of this procedure was assessed in aggregation assays as described above. 
Preparation of Covaspheres 
MX Covaspheres (0.9 ~ra) were purchased from Duke Scientific (Palo Alto, 
CA). After brief sonication 100/~1 of Covaspheres were added to 100/tg 
of mAb-SBKI5. The protein and the Covaspheres were incubated for 75 rain 
at room temperature then centrifuged at 10,000 g for 2 rain. Any unbound 
sites were blocked by incubation for 15 rain in 20 mM Tris pH 7.3 contain- 
ing 1% BSA. The beads were washed with PBS and briefly sonicated before 
use in immunoprecipitation of full length PTP# or the EGFR/PTPI~ chi- 
mera. A triton soluble lysate from full length PTP# or EGFR/PTPt~ 
chimera-expressing Sf9 cells was added to the SBKI5-Covaspheres, in- 
cubated at 4°C for 1 h, washed with lysis buffer three times, resuspended 
in PBS and used in binding assays. Successful immunoprecipitation by the 
antibody-linked Covaspheres was verified by depletion of the PTPt, reac- 
tivity upon immunoblotting. This antibody has been used to purify full- 
length PTP/~ from St9 cells (Brady-Kalnay and Tonks, 1993). 
The in vitro binding assays also utilized a purified fusion protein, corn- 
prising glutathione S-transferase linked to the NH2-terminus of the ex- 
tracellular segment of PTPt~ (GST/PTP/~). The GST/PTP# fusion protein 
was expressed inE. coli and purified according to Guan and Dixon (1991). 
The GST protein alone (27 kD) was used as a negative control. These GST 
proteins were coupled irectly to Covaspheres byadding 3.9/zg protein per 
/~1 of Covaspheres a described above. 
Covasphere Binding Assays 
The binding assay was performed as described in Mauro et al. (1992). 
Briefly, 10/zg of purified GST proteins were adsorbed to 35-mm petri dishes 
for 30 rain, then remaining unbound sites were blocked with 2% BSA in 
PBS. PTP~-linked Covaspheres (50 #1) were added to the dishes in a final 
volume of 1 ml PBS. Bound Covaspberes were visualized with a Zeiss Ax- 
iophot microscope quipped for epifluorescence using a 20x lens. 
The ability of GST/PTP#-linked Covaspheres toself-aggregate was as- 
sessed by adding 30/~1 of the Covasphere preparation to 2 ml of PBS fol- 
lowed by rotation for 30 rain under low shear conditions. Controls utilizing 
Covaspheres coated with GST alone were performed inparallel. Aggregates 
were visualized with a Zeiss Axiophot microscope as above. 
Various protein-coated Covaspheres described above were also used in 
assays to assess binding to the surface of MvLu mink lung cells or 3"1"3 cells. 
Covaspheres (50 #1) were added in DME plus 10% FBS to confluent 35-mm 
plates of MvLu cells, then incubated with the cells for 30 rain at room tem- 
perature with rocking. The plates were washed 3 times with DME and 
visualized as described above. All antibody competition experiments were 
performed using the anti-peptide antibody to the amino-terminus of the ex- 
tracellular segment of PTP/~. In experiments in which binding was blocked 
with FatY fragments he Covaspheres were preincubated for 30 rain at room 
temperature in 0.6 mg pre-immune or immune Fab' per 50/zl Covaspheres 
in a final volume of 500/~1. The FalY/Covasphere solution was added to the 
cells and incubated for 30 min. Alternatively, the MvLu cells were in- 
cubated for 30 rain with pre-immune or immune serum to PTP#, diluted 
1:500 in culture media, before the addition of 50/~1 of full-length PTP/~- 
linked Covaspheres. 
Results 
PTPIz Is Expressed at the Cell Surface 
Human PTP/~ was expressed in Si9 insect cells by infection 
with recombinant baculoviruses. Three forms of human 
PTP# were expressed: (a) a full-length form (200 kD); (b) 
a soluble form, comprising only the intracellular segment 
EGFR/PTP p. 
ch imera 
full length PTP 
soluble PTP p. 
l I 
PTP# - extra 
l l - -1 -  
DESCRIPTION OF MUTANTS 
extracellular and transmembrane 
domains of the EGF receptor and the 
intracellular domain of PTPp. 
entire coding region of PTP 
intracellular domain of PTP ~. 
expressed as a soluble protein 
extracellular domain, transmembrane 
and 54 amino acids of the intracellular 
domain of PTP p. 
ACTIVITY 
(units/mg total cellular protein) 
0 .36  
0 .45  
12.9  
cytoplasm extracel lular 
region 
Figure 1. Structure and PTPase activity of the various baculovirus-expressed recombinant forms of PTP#. The solid black boxes represent 
PTPase domains. The hatched boxes are fibronectin type-HI repeats and the loop represents he immunoglobniin-like domain. The stippled 
box represents he extracellular domain of the EGF receptor. The PTPase activity is expressed as units per mg of total cellular protein 
above the PTPase activity of lysates from uninfected Sf9 cells which was 0.09 U/mg. 
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Figure 2. Expression of PTP# 
and the EGFR/PTP# chimera 
at the cell surface. This figure 
is an immunoblot of whole 
cell lysates using mAb SBK- 
10 generated against the intra- 
cellular segment of PTP~. 
Lane 1 is from cells express- 
ing full-length PTP~,, Lane 2 
is from PTP~t-expressing cells 
that were subjected to limited 
trypsin treatment. Extracts 
from EGFR/PTP# chimera- 
infected cells without r with 
trypsin treatment are shown in 
lanes 3 and 4, respectively. 
Each lane contains 5 ttg total 
protein. 
containing the PTPase domains (80 kD); and (c) a chimera 
containing the extraceUular nd transmembrane domains of 
the EGF receptor and the intracellular PTPase domains of 
PTP# (195 kD) (see Fig. 1). The activity of these PTPases 
in lysates of infected cells was measured using tyrosine- 
phosphorylated RCM lysozyme as a substrate (Fig. 1). The 
uninfected Sf9 cells displayed low levels of endogenous 
PTPase activity (0.09 U/mg total protein). The soluble form 
of PTP# was expressed at much higher levels (,~140-fold 
over background) than either of the transmembrane forms 
(,'~fivefold over the endogenous activity) (see Fig. 1). The ex- 
pression of the various forms of PTP# was also assessed by 
immunoblotting with antibodies to its intracellular segment. 
Fig. 2 shows that the fuU-length form of PTP# (lane 1 ) and 
the EGFR/PTP/~ chimera (lane 3) are expressed at similar 
levels. Immunoblotting of Sf9 cell lysates expressing the 
Figure 3. Aggregation ofbaculovirus-infected Sf9 cells. This figure shows phase contrast micrographs of uninfected or infected Sf9 cells 
allowed to aggregate under low shear conditions for 1 h. a shows uninfected cells which did not aggregate while the full-length PTP/~ 
infected cells (b), formed large aggregates. Cells infected with recombinant baculoviruses expressing soluble PTP/t (c) or EGFR/PTP/~ 
chimera (d) did not aggregate. 
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Figure 4. Quantitation of aggregation. A Coulter counter is used 
to measure a decrease in particle number as single cells are incor- 
porated into aggregates (percent aggregation). Full-length PTP/z- 
infected cells are represented by the solid squares. Soluble PTP# 
(solid circles) or EGFR/PTP/~ chimera (open circles)-expressing 
cells showed even lower levels of aggregation than the uninfected 
cells (open triangles). Error bars indicate SEM from at least five 
determinations. 
soluble form of PTP# confirmed that it is present at much 
higher levels than the transmembrane forms. 
To verify that PTP/~ and the EGFR/PTPg chimera were 
expressed at the cell surface, trypsin sensitivity assays were 
performed (Brady-Kalnay et al., 1993). This assay involves 
incubation of intact cells with a 0.05 % (wt/vol) trypsin solu- 
tion which allows the protease to act only on the portion of 
molecules expressed at the cell surface. Full-length forms 
are converted into smaller f agments still associated with the 
cell, i.e., possessing their transmembrane and cytoplasmic 
segments. The viability and integrity of the trypsinized cells 
was confirmed by trypan blue dye exclusion. Lysates of 
treated cells were immunoblotted with monoclonal ntibody 
SBK-10 directed against the carboxy-terminal domain of 
PTPg, which thus reacts with both full-length PTP# and the 
EGFR/PTP# chimera. Fig. 2 shows ~90% of full-length 
PTP# (lane 2) and the EGFR/PTPt, chimera (lane 4) were 
degraded after trypsinization, thus suggesting that hese pro- 
teins are expressed predominantly on the cell surface. 
Full Length PTPg Expressed in SJ9 Cells 
Mediates Aggregation 
we have used the nonadbesive Sf9 insect cells and the 
baculovirus expression system to demonstrate hat the pro- 
tein tyrosine phosphatase PTP/~ functions in cell-cell aggre- 
gation. The infected cells were tested in aggregation assays 
which involve the rotation of cells under low shear condi- 
tions (Brackenbury etal., 1977). Samples are counted at var- 
ious time points to measure the incorporation of single cells 
into aggregates. 
Sf9 cells were infected with recombinant baculoviruses, 
harvested and assayed for aggregation. The results of a visual 
inspection of the cells is illustrated in the phase contrast 
micrographs in Fig. 3. While uninfected cells do not aggre- 
gate (a) expression of the full-length form of Fl'P~t, shown 
in b, induces the formation of large aggregates. Cells ex- 
pressing the soluble PTP# (c) or the EGFR/PTPg chimera 
(d) also did not aggregate suggesting that increased phospha- 
tase activity alone was not sufficient for this response. Nei- 
ther overexpression f a nonspecific transmembrane protein 
nor the localization of PTPase activity at the membrane was 
sufficient o induce aggregation. 
Quantitative analysis of the aggregation ofSf9 cells is dis- 
played in Fig. 4. The quantitation, measured using a Coulter 
Counter, is expressed as percent aggregation which is a func- 
tion of decrease in particle number as single cells are incor- 
porated into multicellular aggregates. Uninfected cells dis- 
play low levels of aggregation (mean = 11.7%) whereas 
full-length PTP/~-expressing cells showed high levels of 
aggregation (mean = 39.8%). Cells expressing soluble 
PTP# (mean = 4.6 %) or the EGFR/PTP# chimera (mean 
= -4.1%) showed low levels of aggregation. The negative 
number indicates that the final cell count was higher than the 
initial cell count due to the dissociation f cells during the 
aggregation assay. Control infected cells showed lower levels 
of aggregation than uninfected St9 cells. 
Adhesion molecules are classified by their dependence on 
divalent cations, primarily calcium (Takeichi, 1977). The 
aggregation assay described above was routinely performed 
in Graces insect cell medium which contains 7mM calcium 
chloride. To test whether divalent cations were important for ag- 
gregation, we used a chelating resin to remove them from the 
medium prior to performing the assay. The full-length 
PTP#-expressing cells aggregated qually well with or with- 
out divalent cations (data not shown) suggesting that, like 
Figure 5. Aggregation of 
PTPtt--extra expressing cells. 
In A, the immunoblot shows 
that PTP~-extra (lane 1) and 
full length PTP# (lane 2) are 
expressed at similar levels. 
The anti-peptide antibody 
used in this immunoblot 
recognizes a sequence (resi- 
dues 42-57) at the amino-ter- 
minus of PTP/~. Each lane 
contains 5/~g protein. B is a 
phase contrast micrograpb of 
PTP/~-extra expressing cells 
after a 1 h aggregation assay. 
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Figure 6. Analysis of phosphotyrosine levels of infected Sf9 cells. 
The BIRK (tyrosine kinase)-infected (a, lane 1 and b, lane 1) or 
BIRK-tropomyosin co-infected (a, lane 2) cells showed high levels 
of anti-phosphotyrosine immunoreactivity. Co-infection of BIRK 
and full length PTP# produced a reduction in signal that was un- 
changed before (b, lane 2) and after aggregation of the cells (b, lane 
3). The same amount of recombinant PTP# baculovirus was added 
in single or co-infection experiments. Each lane contains 30 #g 
protein. 
other members of the Ig-superfamily ofadhesion molecules, 
it functions in a divalent cation-independent manner. 
Phosphatase Activity Is not Required for Aggregation 
To test whether phosphatase activity is required for the adhe- 
sive function, we generated a mutant form of PTP/z contain- 
ing the entire extracellular domain, transmembrane domain 
and 54 amino acids of the intraceUular domain, which we 
termed PTP#-extra. This protein lacks both phosphatase do- 
mains. As expected, in lysates of ceils expressing PTP#- 
extra, no PTPase actvity above that found in uninfected cells 
was detected. An immunoblot using an antipeptide antibody 
directed against he NH2-terminal extracellular segment of 
PTP# (Fig. 5 a) illustrates that PTP#-extra (lane 1 ) is ex- 
pressed at similar levels to the full-length protein (lane 2). 
The ability of PTP#-extra expressing cells to aggregate is
shown in Fig. 5 b. Quantitative analysis of the assays indi- 
cated a percent aggregation fthe PTP#-extra infected cells 
of 30.3% + 4.3 (mean + SEM, n = 8), compared to 38.2% 
+ 1.9 (mean -1- SEM, n = 6) for full-length PTP#-infected 
cells. Thus, the adhesive function of PTP# and its capacity 
to dephosphorylate proteins are not mutually dependent. 
A common feature of receptor-like molecules is that the 
enzymatic activity of their intracellular domains is regulated 
by binding of ligands to their extracellular segments. We thus 
sought o examine whether aggregation might affect he ac- 
tivity of PTP#. To this end, the levels of total cellular phos- 
photyrosine were analyzed. St9 cells contain very low levels 
of phosphotyrosine-containing proteins. To increase the 
amount of cellular phosphotyrosine and the variety of poten- 
tial substrates, we infected the cells with a recombinant 
baculovirus expressing BIRK, a soluble protein comprising 
the catalytic domain of the mammalian i sulin receptor tyro- 
sine kinase (Villalba et al., 1989). There are many examples 
of direct protein:protein and enzyme:substrate interactions 
that have been investigated byco-infection of St9 cells with 
distinct recombinant baculoviruses (Kaplan et al., 1990; 
Parker et al., 1991; Kato et al., 1993). In light of these 
reports, we co-infected two batches of St9 cells. One batch 
was co-infected with baculoviruses xpressing BIRK and a 
nonphosphatase control (tropomyosin) and the other batch 
with BIRK and full-length PTP/z. Cell lysates were then ana- 
lyzed for changes inphosphotyrosine levels. Fig. 6 is an im- 
munoblot, using anti-phosphotyrosine a tibodies, of extracts 
from cells infected with BIRK (Fig. 6 a, lane 1) or co- 
infected with BIRK and tropomyosin (a, lane 2). The co- 
infection with the non-phosphatase control did not alter the 
BIRK-induced increase in phosphotyrosine levels. The pres- 
ence of tropomyosin protein was confirmed by immunoblot- 
ring (data not shown). Fig. 6 b shows that while high levels 
of phosphotyrosine containing proteins were seen in BIRK- 
infected cells (lane 1) co-infection with BIRK and full-length 
PTP/~ (lane 2) resulted in a dramatic decrease in phos- 
photyrosine l vels, presumably due to high basal activity of 
the PTPase. Immunoblotting verified that full-length PTP# 
was expressed at similar levels in the single or co-infected 
SiX) cell lysates. The overall levels and pattern of anti- 
phosphotyrosine immunoreactive proteins were unchanged 
by aggregation. BIRK/full-length PTP# expressing cells be- 
fore (lane 2) and after (lane 3) aggregation are shown in Fig. 
6 b. Co-infection of BIRK and the soluble PTP/z, which is 
expressed at,,o25-fold higher levels than the transmembrane 
forms, as determined by activity assays, contained even 
lower levels of anti-phosphotyrosine reactivity, suggesting 
that the immunoreactive bands were indeed tyrosine phos- 
phorylated proteins. In addition to this in vivo assay, total 
cell lysates of full-length PTP#-infected cells were assayed 
for PTPase activity with RCM lysozyme as a substrate, be- 
fore and after aggregation. The activity was essentially un- 
changed after aggregation. 
PTPI~ Mediates Homophilic Aggregation 
We have tested whether the aggregation fSi9 cells express- 
ing PTP/~ is mediated via a homophilic mechanism inwhich 
molecules of PTP/~ on different cells interact with one an- 
other or by a heterophilic mechanism in which the insect 
cells express a molecule that binds to human PTP#. Unin- 
fected nonadhesive SiX) cells were labeled with the fluores- 
cent lipophilic dye, Di I (Snow et al., 1989) and mixed with 
unlabeled full-length PTP#-infected cells. After aggregation 
the cells were visualized using an epifluorescence micro- 
scope. The Di I labeled cells did not aggregate and did not 
contribute to the aggregates formed by the full-length PTP/~- 
infected cells. Fig. 7 is a representative example of 32 ag- 
gregates examined in three independent xperiments; no Di 
I-positive cells were seen i  any of the aggregates. These 
results strongly suggest that PTP/z binds in a homophilic 
fashion. 
Reconstitution fPTPiz-mediated Homophilic 
Binding In Vitro 
We have examined the ability of baculovirus-expressed 
PTP/~ to bind to surfaces coated with bacterially-expressed 
extracellular segment of PTP/z in vitro. A mAb to the intra- 
cellular domain of PTP/~ was covalenfly linked to Cova- 
spheres (fluorescent beads). These antibody-linked Cova- 
spheres were used to immunoprecipitate either the full 
length PTP# or the EGFR/PTPp chimera from lysates of in- 
fected cells. The entire extracellular domain of PTP/~ was ex- 
pressed as a glutathione S-transferase (GST) fusion protein 
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Figure 7. Aggregation f Sf9 cells expressing PTP# occurs through 
homophilic binding, a is  representative phase contrast micro- 
graph of an aggregation experiment in which Di I labeled unin- 
fected Sf9 cells were mixed with full-length PTP/z-expressing cells 
before aggregation, b shows the same field as a photographed using 
an epifluorescence microscope to visualize the Di I. The Di I la- 
beled uninfected ceils did not contribute to the large aggregate. This 
is a representative picture of 32 such aggregates examined in three 
independent experiments. 
and purified from E. coli using a glutathione Sepharose 
affinity column. This purified protein was adsorbed onto 
petri dishes and the binding of PTP# or EGFR/PTP# 
chimera-coated Covaspheres was visualized using an epiflu- 
orescence microscope after washing the dishes to remove 
nonadherent Covaspheres. There was no significant binding 
of the full-length PTP# Covaspheres toGST alone [29 + 0.6 
Covaspheres per field (mean + SEM: n = 6) shown in Fig. 
8 a]. Similarly, Fig. 8 b shows that there was no significant 
binding of EGFR/PTP# chimera-coated Covaspheres tothe 
GST/PTP# extracellular segment (28 + 3.9 Covaspheres per 
field: n = 8). However, Fig. 8 c demonstrates that the full- 
length PTP#-coated Covaspheres bound specifically to the 
GST/PTP# extraceUular segment fusion protein (764 + 41 
Covaspheres per field: n = 5). These data establish that the 
homophilic binding in vitro, which was performed in PBS, 
was independent of any added ivalent cations. Also because 
the GST/PTP# protein was isolated from bacteria, glycosy- 
lation of the extracellular domain is unlikely to contribute to 
the binding reaction. Similar observations were made for Nr- 
CAM (Mauro et al., 1992). 
Baculovirus Expressed PTP# Binds by a 
Homophilic Mechanism to PTPIz that Is Normally 
Expressed in MvLu Cells 
We have examined the ability of PTP# to bind homophili- 
cally when expressed atphysiological levels. At this time, the 
only cell line we have found that expresses PTP# is MvLu 
mink lung cells. This cell line expressed low but detectable 
levels of the enzyme as determined by immunoblotting with 
intracellular segment-directed monoclonal anti-PTP/~ anti- 
bodies (data not shown). The ability of PTPlt-coated Cova- 
spheres to bind to these cells was tested. As shown in Fig. 
9, a and b, only low levels of the EGFR/PTP/x chimera- 
coated Covaspheres bound nonspecifically tothe cells while 
high levels of binding of PTP/x-coated Covaspheres were 
observed (c and d). This binding was inhibited by pre-incu- 
bating the MvLu cells with antibodies to the extracellular 
domain of PTP/~ (e and f) .  Pre-immune IgG did not affect 
the binding of PTP/z-coated Covaspheres (Table I). This 
"sided" experiment selectively blocks PTP# on the MvLu 
cells, thus illustrating that binding occurs through a homo- 
philic interaction. In a separate xperiment, Fab' fragments 
of antibodies to PTP# were pre-incubated with the PTP#- 
coated Covaspheres, which also prevented binding. Incuba- 
tion with Fab' fragments derived from pre-immune serum 
did not affect he binding. A quantitative summary of the 
results of Covasphere binding are presented in Table I. These 
data demonstrate that purified PTP# was capable of binding 
homophilically to PTP/z expressed on the surface of MvLu 
cells. 
GST/PTPlz-coated Covaspheres Aggregate In Vitro and 
Bind to MvLu Cells 
In light of the preceding data, one might anticipate hat Cova- 
spheres coated with PTP/z would self-aggregate. To test this 
possibility the GST/PTP# fusion protein was covalently cou- 
pled directly to Covaspheres to ensure a high protein:bead 
ratio. The Covaspheres were then rotated under low shear 
conditions to allow any aggregation to occur. As shown in 
Fig. 10, the Covaspheres coated with GST alone did not ag- 
gregate (a) whereas the GST/PTPft-coated Covaspheres 
formed aggregates (b). These Covaspheres were also exam- 
ined for their ability obind to the surface ofMvLu cells (Ta- 
ble II). While there was no significant binding of control 
GST Covaspheres, GST/PTP/z Covaspheres bound at high 
levels to MvLu cells. Furthermore, the GST/PTP# Cova- 
spheres did not bind to 3T3 cells which do not express de- 
tectable amounts of immunoreactive PTPtt. 
Discussion 
The cloning of receptor-type PTPases has led to the conver- 
gence of the fields of cell adhesion and protein tyrosine de- 
phosphorylation. The structural similarity of some of the 
receptor-type PTPases to the immunoglobulin superfamily 
of cell adhesion molecules uggests hat these phosphatases 
may participate inhomophilic binding interactions, i.e., the 
"ligand" for one of these PTPases may be a molecule of the 
same enzyme xpressed on an adjacent cell. 
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Figure 8. Binding of 
baculovirus-expressed PTP/z- 
linked Covaspheres to sur- 
faces coated with purified 
fusion protein containing 
the extracellular segment of 
PTPI~ (GSTIPTPt~). a shows 
that there were only low 
levels of nonspecific binding 
of full-length PTPtL-coated 
Covaspheres to petri dishes 
coated with GST protein 
alone. Similarly, only low lev- 
els of nonspecific binding 
were seen when the EGFR/ 
PTP# chimera-coated Cova- 
spheres were added to GST/ 
PTP# fusion protein-coated 
dishes (b). However, numer- 
ous full length PTP#-eoated 
Covaspheres bound to the 
GST/PTP/x fusion protein- 
coated ishes (c). 
In this manuscript we report experiments which demon- 
strate homophilic binding between molecules of PTP/~ by 
several criteria: (a) Expression of full-length PTP#, or mu- 
tant forms with an intact extracellular segment, in the pres- 
ence or absence of the PTPase domains, caused St9 cells to 
aggregate. Neither a chimeric phosphatase bearing the ex- 
tracellular segment of the EGF-receptor and the intraeellular 
segment of PTPt~ nor the PTPase domains of PTP/z ex- 
pressed as a soluble protein induced aggregation. When 
uninfected, fluorescently labeled Sf9 cells were mixed with 
unlabeled PTP/~-expressing cells, the labeled cells were ex- 
cluded from the aggregates. Furthermore, no immunoreac- 
tive species were detected after immunoblot analysis of ly- 
sates of uninfected Sf9 cells using a variety of mAbs to 
PTP#. These data indicate that the counter-receptor for 
PTP# was only found on the surfaces of other PTP/~- 
expressing cells. (b) The binding reaction has been recon- 
stituted in vitro. First, fluorescent Covaspheres linked to 
baculovirus expressed PTP/z will bind to petri dishes coated 
with a GST fusion protein (GST/PTP/~) containing the ex- 
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Figure 9. Homophilic binding of baculovirus-expressed PTP~-coated Covaspheres to endogenous PTP# in MvLu cells. Phase contrast 
micrographs of MvLu cells (a, c, and e) and micrographs of fluorescent Covasphere binding (b, d, and f)  are shown, a nd b show the 
low level of nonspecific binding when EGFR/PTP/~ chimera-coated Covaspheres are applied to the cells, c and d, show f~l-length PTP#- 
coated Covaspheres bound to the cells. In e and f, the MvLu cells were preincubated with an anti-peptide antibody to the amino-terminus 
of PTP# before addition of the PTP#-bound Covaspheres. 
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Table I. Quantitation f the Binding of PTP/z-coated 
Covaspheres to MvLu Cells 
Number bound/field* 
PTP#-Covaspheres 
EGFR/PTP# chimera-Covaspheres 
PTP#-Covaspheres pretreated with 
preimmune Fab' 
PTP#-Covaspheres pretreated with 
anti-PTP/~ Fab' 
PTP#-Covaspheres added to MvLu cells 
pretreated with pre-immune antibody 
PTP#-Covaspheres added to MvLu cells 
pretreated with anti-PTP/~ antibody 
539 (+ 94) 
9 (+ 2) 
475 (:t: 39) 
15 (+ 3) 
401 (:t: 10) 
19 (+ 3) 
* The number of Covaspheres bound is represented as the mean of at least three 
fields. The field is 0.09 nun 2. The number in parentheses indicates SEM. Some 
of these results are illustrated inFig. 9. 
tracellular segment of PTP# purified from E. coli, but will 
not bind to GST alone. Furthermore, Covaspheres linked to 
the EGFR/PTP# chimera bind neither GST nor GST/PTP#. 
Secondly, Covaspheres coated with GST/PTP# fusion pro- 
tein self-aggregate, whereas those coated with GST alone do 
not. (c) We show that PTP#, as it is expressed endogenously 
on MvLu cells, retains the capacity to interact with baculo- 
virus-expressed PTP# linked to Covaspheres. While PTP#- 
coated Covaspheres bind to MvLu cells, EGFR/PTP# Cova- 
spheres do not. Binding of PTP# Covaspheres i blocked by 
pretreating the cells with antibody to the extracellular seg- 
ment of PTP/z but not by a control pre-immune antibody. 
Table II. Quantitation fCovasphere Binding to Cell 
Surfaces 
Number bound/field* 
GST-Covaspheres added to MvLu cells 12 (+ 2) 
GST/PTP#-Covaspheres added to MvLu cells 1,006 (+ 78) 
GST/PTPtz-Covaspheres added to 3T3 cells 9 (+ 2) 
* The number of Covaspheres bound is represented as the mean of at least six 
fields. The field is 0.09 ram: and contained approximately qual numbers of
MvLu and 3T3 cells. The number inparentheses indicates SEM. 
Also if the PTP# Covaspheres are pretreated with Fab' frag- 
ments from the anti-PTP# antibody, binding to MvLu cells 
is blocked whereas control FalYs are without effect. Collec- 
tively, these data establish homophilic binding between 
PTP# molecules in a beterologous expression system, in in 
vitro binding assays and in cells in which the molecule is nor- 
mally expressed. 
For immunoglobulin superfamily-type adhesion mole- 
cules, such as N-CAM, aggregation is highly dependent 
upon the concentration of the molecule at the cell surface 
(Hoffman and Edelman, 1983). Therefore, to assess the 
aggregation potential of PTP# a model system had to be used 
that could generate high level expression of the protein at the 
cell surface. Introduction of potential adhesion molecules 
into nonadhesive cells has been used to demonstrate directly 
their adhesive functions. Transfection for determination f 
an adhesive function was first described by Takeichi and col- 
leagues for E-cadherin (Nagafuchi et al., 1987). Goodman 
Figure 10. GST/PTP#-coated 
Covaspheres aggregate in vi- 
tro. Covaspheres coated with 
GST alone or GST/PTP# 
were used in an in vitro aggre- 
gation assay and visualized 
by an epifluorescence mi- 
croscope. GST Covaspheres 
did not aggregate (a) where- 
as GST/PTP# Covaspheres 
formed aggregates (b). 
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and co-workers introduced fasciclin III and connectin mole- 
cules into nonadhesive Drosophila $2 cells to demonstrate 
that these molecules mediated homophilic adhesion (Snow 
et al., 1989; Nose et al., 1992). Similarly, Pulido et al. 
(1992) have used Drosophila $2 cells to demonstrate that he 
receptor tyrosine kinase, Dtrk, may function as an adhesion 
molecule. We chose to use St9 insect cells and the baculovi- 
rus expression system (Matsuura et al., 1987; Summers and 
Smith, 1987) to express PTP#. This system has been used 
previously to express high levels of glycosylated, biologi- 
cally active haemagglutinin (Kuroda et al., 1986) and tissue 
plasminogen activator (Jarvis and Summers, 1989). An ad- 
ditional requirement for use in adhesion studies is a 
baculovirus-susceptible cell line with low levels of endoge- 
nous aggregation. Sf9 cells fulfill this condition in that they 
do not aggregate well in an in vitro assay. 
The St9 cells infected with full length PTP# showed high 
levels of aggregation (39%) compared to uninfected cells 
(11.9 %), and the even lower levels of aggregation fcells in- 
fected with soluble PTP# (4.6%) or the EGFR/PTP# chi- 
mera (-4.1%). The level of aggregation i duced by PTP# 
was similar to that induced by other known adhesion mole- 
cules in various model systems. For example, transfection f
mouse L-cells with N-CAM resulted in a difference in aggre- 
gation of 30% (Edelman et al., 1987) whereas N-CAM ex- 
pression increased aggregation fan RSV-transformed neu- 
ronal cell line from 20 to 40% (Brady-Kalnay et al., 1993). 
Expression of Nr-CAM in L-cells increased aggregation to
14% (Mauro et al., 1992) while Nose et al. (1989) detected 
a 50 % difference in aggregation of fasciclin III-transfected 
versus untransfected $2 cells. Therefore, PTP# promotes 
similar levels of aggregation tothose detected in response to 
well established cell-cell adhesion molecules. These data 
suggest that the St9 cell/baculovirus expression system may 
represent a useful tool for revealing potential adhesive func- 
tions for other molecules. 
Whether or not PTP# has the ability to perform this adhe- 
sive function in its normal environment remains to be deter- 
mined. Nevertheless, we have shown that PTP# expressed 
endogenously on the surface of MvLu cells retains the ca- 
pacity for homophilic binding. However, MvLu cells do not 
aggregate in an aggregation assay. The low levels of the 
PTPase expressed in these cells may preclude the successful 
application of this assay. We have observed PTP# protein to 
be expressed abundantly in lung, however at present we have 
not found a cell line that reflects that high level of expression. 
Thus, the ultimate resolution of the issue of whether, as sug- 
gested by the data presented in this manuscript, PTP# can 
function as an adhesion molecule in vivo may require the use 
of primary cell systems. 
High local concentrations in a specific area of the mem- 
brane could allow PTP# to bind homophilically and function 
in an adhesive role even though it may be expressed at low 
overall evels in a particular cell. One novel feature of PTP# 
that may be interesting in this regard is that its intracellular 
juxtamembrane s gment is 70 amino acids longer than the 
equivalent segment in other receptor PTPases. Using the 
ALIGN program, we have shown that this portion of PTP# 
displays equence similarity to the intracellular segment of 
members of the cadherin family (Tonks et al., 1992). This 
homology is interesting because no other receptor type 
PTPases have such similarity to the cadherins, nor do any 
other members of the immunoglobulin superfamily. The in- 
tracellular domain of the cadherins i  the most highly con- 
served segment ("°90% identity) among members of this 
family (reviewed by Takeichi, 1991) and interacts indirectly 
with the actin cytoskeleton (Ozawa et al., 1989). The cadhe- 
rins are found at areas of cell contact, for example adherens- 
type cell junctions (Tsukita et al., 1991). Such cell junctions 
are areas of rapid phosphotyrosine turnover and locations at 
which tyrosine kinases including src and pp125 ear are con- 
centrated in normal and transformed cells (Volberg et al., 
1991; Guan and Shalloway, 1992). In fact, changes in tyro- 
sine phosphorylation may be involved in controlling the 
structural integrity of these junctions (Volberg et al., 1992). 
In light of this homology to the cadherins it is possible that 
PTP# may also associate with the cytoskeleton through an 
interaction with accessory molecules at points of cytoskel- 
etal-membrane association such as intercellular junctions. 
PTP# displays phosphatase activity after expression i Sf9 
cells. To address the possibility that phosphatase activity was 
a requirement for cell-cell aggregation, we made a mutant 
form of PTP#, PTP#-extra, that lacked both phosphatase do- 
mains. This form of PTP/z induced aggregation with similar 
efficiency to the full-length form indicating that phosphatase 
activity and the aggregation response were not mutually de- 
pendent. Furthermore, the fact that he bacterially-expressed 
fusion protein GST/PTP# containing only the extracellular 
segment of the PTPase was able to induce binding in vitro 
also suggested that aggregation was mediated solely by the 
extracellular domain. Aggregation did not result in dramatic 
changes in cellular phosphotyrosine levels as determined by 
anti-phosphotyrosine mmunoblots. These data raise the 
possibility that, unlike the growth factor receptor PTKs 
where binding of the ligand to the extracellular segment trig- 
gers the kinase activity of the intracellular domain, PTP# ac- 
tivity may not be strictly dependent upon ligand binding. 
However, this should be considered in light of the caveat that 
it is unlikely that Sf9 insect cells contain the normal sub- 
strates for human PTP#. Changes in activity or affinity for 
a particular substrate may be seen when two molecules of 
PTP/z contact one another in their normal environment. 
Nevertheless, one could also propose a tethering role for 
homophilic binding interactions among PTP# extracellular 
segments. Thus, the spatial distribution of the enzyme on the 
cell surface may be restricted, for example to intercellular 
junctions, with concommitant restriction of the spectrum of 
substrates or regulatory proteins with which it can interact. 
PTP# offers a unique, potentially direct link between cell 
adhesion phenomena and the triggering of signal transduc- 
tion pathways. It remains possible that PTP# itself may not 
directly promote cell-cell adhesion in vivo. However, in the 
context of adhesion driven by PTP#-independent binding 
mechanisms, homophilic interactions between apposing 
PTP# molecules may alter their phosphatase activity. Thus 
the homology of PTP/z to the cadherins, N-CAM-like mole- 
cules and PTPases predicts an interesting role in cell-cell 
communication a d continuing studies of PTP# should yield 
important new insights into the control of signal transduction 
processes. 
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